KRT19 and cancer: further found that cancer cells could restrict T-cell motility and suppress the intratumoral accumulation of T cells by assembling a transglutaminase-2 (TGM2)-dependent filamentous coating of CXCL12-keratin-19 (KRT19) heterodimers (31).